Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ORGANIZATION
ORGANIZATION
- PhRMA Chair Prods Japan to Permanently Install Key Pricing Premium
November 20, 2014
- Ihoken Proposes Revision of Compensation Guidelines to Include Compensation for Injury Due to Anticancer Drugs
November 20, 2014
- Mr Aoyagi of JPMA Calls for Negotiating Invoice Prices for Individual Products
November 17, 2014
- No Nippon Pharmacy Association Affiliated Pharmacy Will Be Subject to Medical Fee Cut Rule: Survey
November 17, 2014
- JPMA, JPPA, and JPWA Express Strong Opposition to Annual NHI Price Revision
November 4, 2014
- EFPIA Japan Official Calls for More-Effective Use of Surplus Raw Plasma
October 30, 2014
- April-June Generic Share at 49.8% under New Formula: JGA
October 29, 2014
- JPMA to Launch Compound Library Joint Purchasing Initiative; Full-Scale Purchasing to Begin in FY2015
October 29, 2014
- FPMAJ Sets Up Panel to Discuss Selective Sales Tax Breaks
October 27, 2014
- Japan CRO Association Nearing Remote Verification Agreement with Cancer Treatment Center
October 22, 2014
- JPMA Tones Down Demand on R&D Tax Credit System, Calls for “Maintenance” Instead of “Perpetuation”
October 20, 2014
- JMA Pres. Frets Proposed Introduction of Reference Pricing Rule
October 17, 2014
- JPMA Decides on More Close-Up Disclosure for R&D Outlays
October 17, 2014
- Industry Associations Call for Delay in Ratification of COP10 Nagoya Protocol
October 10, 2014
- US Nonprofit ACRES Launches Japan Branch
October 8, 2014
- National University Hospital Council’s Guidelines Not to Require Disclosure of Individuals’ Names
October 7, 2014
- JPMA Plans Disclosure of Recipients, Amount of Payments for R&D Outlays
October 3, 2014
- Bayer Yakuhin President to Become New EFPIA Japan Chairman
October 2, 2014
- JPMA Weighs Disclosure of Ad Payments to Commercial Medical Publishers
September 26, 2014
- JPMA to Unify Method of Disclosing Sensitive Payment Information from Next Year
September 22, 2014
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…